Does Dr. VIVIAN ABOKO-COLE HICKS have financial conflicts of interest?

Dr. VIVIAN ABOKO-COLE HICKS (M.D.) has received a total of $2,337 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,337 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. VIVIAN ABOKO-COLE HICKS?

According to CMS Open Payments data, Dr. VIVIAN ABOKO-COLE HICKS received funding from ASTRAZENECA PHARMACEUTICALS ($1,114), BAYER HEALTHCARE PHARMACEUTICALS ($641), and BOEHRINGER INGELHEIM PHARMACEUTICALS ($349).

Does Dr. VIVIAN ABOKO-COLE HICKS receive research grants or speaking fees?

Dr. VIVIAN ABOKO-COLE HICKS has received $2,337 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. VIVIAN ABOKO-COLE HICKS

M.D.Real-Time Hydrated

Specialty: Internal Medicine

Practice Location: HUNTSVILLE, AL 35801

NPI Number: 1316023708

LIFETIME INDUSTRY VALUE

$2,337

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABOKO-COLE HICKS is a verified Internal Medicine practitioner based in HUNTSVILLE, AL.

Between 2021 and 2024, Dr. ABOKO-COLE HICKS had an overall industry promotional and research financial footprint of $2,337 as recorded in the federal CMS Open Payments database.

$2,337 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABOKO-COLE HICKS's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $1,114 (representing 47.7% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$1,114

47.7%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 2

$641

27.4%

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 3

$349

14.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.